Today is the birthday, or anniversary, of the boards starting September 30, 2000 (The rest of the site started earlier that year on July 21, 2000)
As of today, we have 72,796 members who have made countless posts.
Find the message boards here: http://cushings.invisionzone.com/
Murfreesboro Medical Clinic & SurgiCenter
272 Garrison Drive
Murfreesboro, TN 37129
615-893-4480
Murfreesboro Medical Clinic & SurgiCenter is committed to meeting the needs of Rutherford County’s growing community. In addition to adding two new locations in 2019, MMC will be adding five new doctors to its team of physicians.
The physicians joining MMC this fall are: Christopher Albergo, M.D. (Endocrinology), Lauren Blackwell, D.O. (Pediatrics), C. Brad Bledsoe, M.D. (Dermatology), Britni Caplin, M.D. (ENT), and Brittany Cook, M.D. (Ophthalmology).
“With a national shortage of physicians, it is becoming more and more challenging to find quality physicians to meet the growing healthcare needs of our community,” noted Joey Peay, MMC’s Chief Executive Officer. “For MMC to find five quality physicians to join us in 2019 in addition to the nine that began practicing at MMC in 2018 is truly remarkable! Each of them will be a valuable member of our medical team and a wonderful member of the Murfreesboro community.”
Christopher Albergo, M.D. is a board-certified Endocrinologist skilled in general endocrinology, including Hypothyroid, Parathyroid, Thyroid Cancer, Graves’ Disease, Pituitary disorders, Adrenal disorders, Hypogonadism , PCOS, Obesity, Diabetes and Osteoporosis.
Read about all the new doctors here: https://www.wgnsradio.com/murfreesboro-medical-clinic-surgicenter-is-proud-to-announce-the-addition-of-five-new-physicians-to-its-practice-in-2019–cms-53464
Andrew Lin, MD
Neuro-Oncologist & Neurologist
Memorial Sloak Kettering Cancer Center
After registering you will receive a confirmation email with details about joining the webinar.
Contact us at webinar@pituitary.org with any questions or suggestions.
During the conversation I will be:
1) Defining aggressive pituitary tumors.
2) Reviewing the current treatment options for aggressive pituitary tumors.
3) Discussing experimental treatment options including a phase II trial investigating the activity of the immunotherapies nivolumab and ipilimumab.
I am a neuro-oncologist at Memorial Sloan Kettering Cancer Center (MSK) and a member of the Multidisciplinary Pituitary & Skull Base Tumor Center. In collaboration with my colleagues in endocrine, neurosurgery, and radiation oncology, I treat patients with aggressive pituitary tumors, who are resistant to conventional treatments (i.e. surgery and radiation), with chemotherapy. With my colleagues at MSK, I have published several research articles on pituitary tumors and opened several clinical trials.